Table 3 Cross-tabulation of risk status, group allocation, and statin prescription after the intervention with arriba TM
Risk group | Statins | Total | Odds ratios | |||
|---|---|---|---|---|---|---|
No | Yes | (95% confidence interval) | ||||
Group 1 very high risk | Intervention | n | 3905 | 1183 | 5088 | Â |
% | 76.7% | 23.3% | 100.0% | Â | ||
Controls | n | 3409 | 1069 | 4478 | 1.04 | |
% | 76.1% | 23.9% | 100.0% | (0.94-1.14) | ||
Group 2 high risk | Intervention | n | 14003 | 1735 | 15738 | Â |
% | 89.0% | 11.0% | 100.0% | Â | ||
Controls | n | 12383 | 1469 | 13852 | 0.96 | |
% | 89.4% | 10.6% | 100.0% | (0.89-1.03) | ||
Group 3 intermediate risk | Intervention | n | 2686 | 149 | 2835 | Â |
% | 94.7% | 5.3% | 100.0% | Â | ||
Controls | n | 2459 | 127 | 2586 | 0.93 | |
% | 95.1% | 4.9% | 100.0% | (0.73-1.19) | ||
Group 4 low risk | Intervention | n | 16823 | 538 | 17361 | Â |
% | 96.9% | 3.1% | 100.0% | Â | ||
Controls | n | 15724 | 477 | 16201 | 0.95 | |
% | 97.1% | 2.9% | 100.0% | (0.84-1.08) | ||